Author: | Chapman, P. B. |
Article Title: | T-cell chauvinists versus antibody advocates - Can't we all just get along? |
Keywords: | signal transduction; vasculotropin; bevacizumab; nonhuman; antineoplastic agents; note; rituximab; antineoplastic agent; neoplasm; neoplasms; t lymphocyte; t-lymphocytes; cancer immunotherapy; melanoma; breast cancer; epidermal growth factor receptor; epidermal growth factor receptor 2; editorial; cytotoxicity; cetuximab; cancer research; monoclonal antibody; lung metastasis; b cell lymphoma; cd20 antigen; immunology; antibodies, monoclonal; nonhodgkin lymphoma; cellular immunity; immunotherapy; antigen specificity; ganglioside gd2; colon cancer; fc receptor; trastuzumab; tyrosinase related protein 1; ganglioside gd3; ganglioside gm2; phagocyte; dna polymorphism; immunization; antibody conjugate; immunoconjugates; humans; human; priority journal; monoclonal antibody r24 |
Journal Title: | Journal of Clinical Oncology |
Volume: | 22 |
Issue: | 22 |
ISSN: | 0732-183X |
Publisher: | American Society of Clinical Oncology |
Date Published: | 2004-11-15 |
Start Page: | 4446 |
End Page: | 4448 |
Language: | English |
DOI: | 10.1200/jco.2004.06.939 |
PUBMED: | 15483013 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Cited By (since 1996):3 -- Export Date: 16 June 2014 -- CODEN: JCOND -- Source: Scopus |